EPH158 Assessing the Public Health Benefit of a mRNA-Based Respiratory Syncytial Virus Vaccine (mRNA-1345) Among Adults ≥65 Years in France
Abstract
Authors
N El Mouaddin M Uhart L Abily P Ghaswalla K Joshi K Fust M Kohli L Biron J Carette